APTO - Aptose Biosciences Inc.

QQQ $ 430.17 $ -2.06 (-0.48 %)

DIA $ 380.88 $ -3.52 (-0.92 %)

SPY $ 507.81 $ -1.92 (-0.38 %)

TLT $ 87.78 $ -0.61 (-0.69 %)

GLD $ 215.92 $ 1.28 (0.6 %)

Previous Close

$ 1.16

Open

$ 1.17

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 1.16 - $ 1.17

52 Week Range

$ 1.15 - $ 8.70

Volume

47,081

Average Volume

Market Cap

7.84M

Beta (5Y Monthly)

$ 0.83

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-26-2024	12-31-2023	10-K
2	11-09-2023	09-30-2023	10-Q
3	08-10-2023	06-30-2023	10-Q
4	05-08-2023	03-31-2023	10-Q
5	03-24-2023	12-31-2022	10-K
6	11-01-2022	09-30-2022	10-Q
7	08-02-2022	06-30-2022	10-Q
8	05-09-2022	03-31-2022	10-Q
9	03-22-2022	12-31-2021	10-K
10	11-12-2021	09-30-2021	10-Q
11	08-03-2021	06-30-2021	10-Q
12	05-04-2021	03-31-2021	10-Q
13	03-23-2021	12-31-2020	10-K
14	11-10-2020	09-30-2020	10-Q
15	08-04-2020	06-30-2020	10-Q
16	05-05-2020	03-31-2020	10-Q
17	03-10-2020	12-31-2019	10-K
18	11-05-2019	09-30-2019	10-Q
19	08-06-2019	06-30-2019	10-Q
20	05-07-2019	03-31-2019	10-Q
21	03-12-2019	12-31-2018	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Piper Sandler Maintains Overweight on Apto...
04/03/2024 15:58:46

Piper Sandler analyst Edward Tenthoff maintains Aptose Biosciences (NASDAQ:APTO) with a Overweight and maintains $5 price ta...

HC Wainwright & Co. Maintains Buy on Aptos...
03/27/2024 10:22:53

HC Wainwright & Co. analyst Joseph Pantginis maintains Aptose Biosciences (NASDAQ:APTO) with a Buy and maintains $23 pri...

Aptose Biosciences Q4 EPS $(1.44) Beats $(...
03/26/2024 20:12:20

Aptose Biosciences (NASDAQ:APTO) reported quarterly losses of $(1.44) per share which beat the analyst consensus estimate of $(...

Recap: Aptose Biosciences Q4 Earnings
03/26/2024 20:10:05

Aptose Reports FY23 Loss Per Share Of $(7....
03/26/2024 20:06:37

Earnings Scheduled For March 26, 2024
03/26/2024 08:47:27

Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on reve...

Aptose Biosciences's Earnings: A Preview
03/25/2024 14:01:06

Piper Sandler Maintains Overweight on Apto...
02/01/2024 20:09:59

Piper Sandler analyst Edward Tenthoff maintains Aptose Biosciences (NASDAQ:APTO) with a Overweight and lowers the price targ...

Aptose Announces Pricing Of Underwritten O...
01/26/2024 13:04:19

SAN DIEGO and TORONTO, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (N...

why-tellurian-shares-are-trading-higher-by-over-16-here-are-20-stocks-moving-premarket

Why Tellurian Shares Are Trading Higher By...
01/26/2024 12:58:39

Shares of Tellurian Inc. (NASDAQ: TELL) shares rose sharply in pre-market trading following a report suggesting the company hi...

Aptose Tuspetinib Clinical Data Featured I...
12/10/2023 13:14:42

Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ:APTO, TSX:APS), a clinical-stage precision oncology company develop...

Aptose Biosciences Files For Offering 4.1M...
12/04/2023 11:19:52

RBC Capital Maintains Outperform on Aptose...
11/10/2023 18:54:13

RBC Capital analyst Gregory Renza maintains Aptose Biosciences (NASDAQ:APTO) with a Outperform and lowers the price target f...

Aptose Biosciences: Q3 Earnings Insights
11/09/2023 21:10:39

Aptose Biosciences Q3 EPS $(1.76) Beats $(...
11/09/2023 21:07:15

Aptose Biosciences (NASDAQ:APTO) reported quarterly losses of $(1.76) per share which beat the analyst consensus estimate of $(...

Earnings Scheduled For November 9, 2023
11/09/2023 11:52:51

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on re...

Aptose Tuspetinib Clinical Data Selected F...
11/02/2023 13:10:57

Aptose Biosciences Inc. ("Aptose" or the "Company") (NASDAQ:APTO, TSX:APS), a clinical-stage precision oncology...

Why ON Semiconductor Shares Are Trading Lo...
10/30/2023 17:55:55

Gainers Miromatrix Medical Inc. (NASDAQ: MIRO) shares climbed 230.7% to $3.3401 after United Therapeutics agreed to acquire...

Aptose Biosciences Announced That Two Abst...
10/16/2023 11:47:51

Stocks That Hit 52-Week Lows On Tuesday
10/03/2023 18:37:58

On Tuesday, 647 companies set new 52-week lows.